ATX 12.0% 8.8¢ amplia therapeutics limited

Ann: Update on ACCENT Trial in Pancreatic Cancer, page-33

  1. 315 Posts.
    lightbulb Created with Sketch. 37
    That is the question seemingly unaddressed in the announcement. Reading between the lines 7 completed more than six months treatment and 2 more than 10 months.
    Assuming that the 2 patients are not a subset on the 7, that means it appears 5 of 14 didn’t survive 6 months. If median survival is 5.5 months this suggests the median survival isn’t much longer with use of Amplia’s agent.
    Cue the outrage from the true believers.
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
8.8¢
Change
-0.012(12.0%)
Mkt cap ! $24.13M
Open High Low Value Volume
12.0¢ 13.5¢ 8.6¢ $614.5K 5.826M

Buyers (Bids)

No. Vol. Price($)
1 122997 8.8¢
 

Sellers (Offers)

Price($) Vol. No.
9.4¢ 11000 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.